Progyny, Inc. (PGNY)

Market Cap	2.08B
Revenue (ttm)	1.21B
Net Income (ttm)	52.50M
Shares Out	85.72M
EPS (ttm)	0.57
PE Ratio	42.84
Forward PE	14.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,686,563
Open	21.66
Previous Close	21.45
Day's Range	21.48 - 24.54
52-Week Range	13.39 - 30.42
Beta	1.31
Analysts	Buy
Price Target	22.86 (-5.81%)
Earnings Date	Aug 7, 2025

About PGNY

Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management s...

• Industry: Healthcare Plans
• Sector: Healthcare
• IPO Date: Oct 25, 2019
• Employees: 680
• Stock Exchange: NASDAQ
• Ticker Symbol: PGNY
• Website: https://www.progyny.com

Financial Performance

In 2024, Progyny's revenue was $1.17 billion, an increase of 7.22% compared to the previous year's $1.09 billion. Earnings were $54.34 million, a decrease of -12.41%.

Analyst Summary

According to 8 analysts, the average rating for PGNY stock is "Buy." The 12-month stock price target is $22.86, which is a decrease of -5.81% from the latest price.

Price Target

$22.86

(-5.81% downside)

Analyst Consensus: Buy